{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:41:27Z","timestamp":1774363287775,"version":"3.50.1"},"reference-count":22,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7,1]]},"abstract":"<jats:p>Objective. Solid organ transplant recipients are at increased risk for invasive pneumococcal disease. The American Academy of Pediatrics recommends immunization with sequential pneumococcal vaccines for this group; however, data are lacking. Accordingly, this study was designed to evaluate the safety and immunogenicity of the recommended regimen.<\/jats:p>\n               <jats:p>Methods. Pediatric solid organ transplant recipients (n = 25) between 2 and 18 years of age who had not previously received 7-valent conjugate pneumococcal vaccine (PCV7) were enrolled. These patients received 2 doses of the PCV7 and a single dose of the 23-valent polysaccharide pneumococcal vaccine (23V). Each vaccine dose was given 2 months apart. Healthy age-matched controls (n = 23) were enrolled for comparison. Controls received a single dose of PCV7 followed 2 months later by a single dose of 23V. Antibody concentrations to serotypes 1, 4, 5, 6B, 9V, 14, 18C, 19F, and 23F were measured by enzyme-linked immunosorbent assay prevaccination, 2 months after each vaccine dose and 5 to 7 months after 23V. Local and systemic reactions to each vaccine dose were recorded.<\/jats:p>\n               <jats:p>Results. Systemic and injection-site reactions were comparable between the 2 groups. Significant rises in serotype-specific pneumococcal antibody geometric mean concentrations from prevaccination levels were observed in both groups; however, final antibody responses to serotypes 1, 4, 9V, 14, 18C, 19F, and 23F were significantly lower in solid organ transplant recipients compared with the control group. Antibody concentrations did not increase significantly among solid organ transplant patients after the second dose of PCV7. No additional increase in PCV7-associated serotype-specific antibody levels was observed after the 23V dose in both groups. Heart transplant recipients had lower antibody responses compared with liver transplant recipients.<\/jats:p>\n               <jats:p>Conclusions. Although the pneumococcal vaccine regimen was safe and immunogenic among pediatric solid organ transplant recipients, the patients did not seem to benefit from the second dose of PCV7 or from the 23V dose given 2 months later. Additional studies are needed to determine the number of PCV7 doses and the interval between PCV7 and 23V to induce optimal responses.<\/jats:p>","DOI":"10.1542\/peds.2004-2312","type":"journal-article","created":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T18:17:49Z","timestamp":1120241869000},"page":"160-167","source":"Crossref","is-referenced-by-count":71,"title":["Safety and Immunogenicity of the American Academy of Pediatrics\u2013Recommended Sequential Pneumococcal Conjugate and Polysaccharide Vaccine Schedule in Pediatric Solid Organ Transplant Recipients"],"prefix":"10.1542","volume":"116","author":[{"given":"Philana Ling","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian G.","family":"Michaels","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Pittsburgh"},{"name":"Department of Surgery and Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Pittsburgh"},{"name":"Department of Surgery and Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George V.","family":"Mazariegos","sequence":"additional","affiliation":[{"name":"Department of Surgery and Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Webber","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy S.","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Iurlano","sequence":"additional","affiliation":[{"name":"Department of Surgery and Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2005,7,1]]},"reference":[{"key":"2021120905523655100_R1","doi-asserted-by":"crossref","unstructured":"Amber IJ, Gilbert EM, Schiffman G, Jacobson JA. Increased risk of pneumococcal infections in cardiac transplant recipients. Transplantation.\u20081990;49:122\u2013125","DOI":"10.1097\/00007890-199001000-00027"},{"key":"2021120905523655100_R2","doi-asserted-by":"crossref","unstructured":"Schroter GP, West JC, Weil R 3rd. Acute bacteremia in asplenic renal transplant patients. JAMA.\u20081977;237:2207\u20132208","DOI":"10.1001\/jama.237.20.2207"},{"key":"2021120905523655100_R3","doi-asserted-by":"crossref","unstructured":"Linnemann CC Jr, First MR. Risk of pneumococcal infections in renal transplant patients. JAMA.\u20081979;241:2619\u20132621","DOI":"10.1001\/jama.241.24.2619"},{"key":"2021120905523655100_R4","doi-asserted-by":"crossref","unstructured":"Petri WA Jr. Infections in heart transplant recipients. Clin Infect Dis.\u20081994;18:141\u2013146, quiz 147\u2013148","DOI":"10.1093\/clinids\/18.2.141"},{"key":"2021120905523655100_R5","doi-asserted-by":"crossref","unstructured":"Schutze GE, Mason EO Jr, Wald ER, et al. Pneumococcal infections in children after transplantation. Clin Infect Dis.\u20082001;33:16\u201321","DOI":"10.1086\/320875"},{"key":"2021120905523655100_R6","doi-asserted-by":"crossref","unstructured":"Stovall SH, Ainley KA, Mason EO Jr, et al. Invasive pneumococcal infections in pediatric cardiac transplant patients. Pediatr Infect Dis J.\u20082001;20:946\u2013950","DOI":"10.1097\/00006454-200110000-00007"},{"key":"2021120905523655100_R7","unstructured":"American Academy of Pediatrics. In: Pickering LK, ed. Redbook: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove, IL: American Academy of Pediatrics; 2003"},{"key":"2021120905523655100_R8","doi-asserted-by":"crossref","unstructured":"Wernette CM, Frasch CE, Madore D, et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol.\u20082003;10:514\u2013519","DOI":"10.1128\/CDLI.10.4.514-519.2003"},{"key":"2021120905523655100_R9","doi-asserted-by":"crossref","unstructured":"Lefebure AF, Verpooten GA, Couttenye MM, De Broe ME. Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients. Vaccine.\u20081993;11:397\u2013399","DOI":"10.1016\/0264-410X(93)90278-6"},{"key":"2021120905523655100_R10","unstructured":"Loinaz C, de Juanes JR, Gonzalez EM, et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology.\u20081997;44:235\u2013238"},{"key":"2021120905523655100_R11","unstructured":"Carey W, Pimentel R, Westveer MK, Vogt D, Broughan T. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am J Gastroenterol.\u20081990;85:1590\u20131592"},{"key":"2021120905523655100_R12","doi-asserted-by":"crossref","unstructured":"Dengler TJ, Strnad N, Buhring I, et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation.\u20081998;66:1340\u20131347","DOI":"10.1097\/00007890-199811270-00014"},{"key":"2021120905523655100_R13","doi-asserted-by":"crossref","unstructured":"Blumberg EA, Albano C, Pruett T, et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis.\u20081996;22:295\u2013302","DOI":"10.1093\/clinids\/22.2.295"},{"key":"2021120905523655100_R14","doi-asserted-by":"crossref","unstructured":"Blumberg EA, Brozena SC, Stutman P, Wood D, Phan HM, Musher DM. Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Infect Dis.\u20082001;32:307\u2013310","DOI":"10.1086\/318482"},{"key":"2021120905523655100_R15","doi-asserted-by":"crossref","unstructured":"McCashland TM, Preheim LC, Gentry MJ. Pneumococcal vaccine response in cirrhosis and liver transplantation. J Infect Dis.\u20082000;181:757\u2013760","DOI":"10.1086\/315245"},{"key":"2021120905523655100_R16","doi-asserted-by":"crossref","unstructured":"Linnemann CC Jr, First MR, Schiffman G. Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch Intern Med.\u20081981;141:1637\u20131640","DOI":"10.1001\/archinte.141.12.1637"},{"key":"2021120905523655100_R17","doi-asserted-by":"crossref","unstructured":"Stark K, Gunther M, Schonfeld C, Tullius SG, Bienzle U. Immunisations in solid-organ transplant recipients. Lancet.\u20082002;359:957\u2013965","DOI":"10.1016\/S0140-6736(02)08028-5"},{"key":"2021120905523655100_R18","doi-asserted-by":"crossref","unstructured":"Vernacchio L, Neufeld EJ, MacDonald K, et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr.\u20081998;133:275\u2013278","DOI":"10.1016\/S0022-3476(98)70235-5"},{"key":"2021120905523655100_R19","doi-asserted-by":"crossref","unstructured":"Overturf GD; American Academy of Pediatrics, Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics.\u20082000;106:367\u2013376","DOI":"10.1542\/peds.106.2.367"},{"key":"2021120905523655100_R20","doi-asserted-by":"crossref","unstructured":"O'Brien KL, Swift AJ, Winkelstein JA, et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group. Pediatrics.\u20082000;106:965\u2013972","DOI":"10.1542\/peds.106.5.965"},{"key":"2021120905523655100_R21","unstructured":"Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J.\u20082000;19:187\u2013195"},{"key":"2021120905523655100_R22","doi-asserted-by":"crossref","unstructured":"Kumar D, Rotstein C, Miyata G, Arlen D, Humar A. Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients. J Infect Dis.\u20082003;187:1639\u20131645","DOI":"10.1086\/374784"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/1\/160\/1033484\/zpe00705000160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/1\/160\/1033484\/zpe00705000160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T23:48:05Z","timestamp":1639093685000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/116\/1\/160\/72910\/Safety-and-Immunogenicity-of-the-American-Academy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,7,1]]},"published-print":{"date-parts":[[2005,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-2312","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,1]]}}}